Location History:
- Plobsheim, FR (2017)
- Strasbourg, FR (2014 - 2018)
Company Filing History:
Years Active: 2014-2018
Title: Johann Foloppe: Innovator in Oncolytic Vectors
Introduction
Johann Foloppe is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of biotechnology, particularly in the development of oncolytic viral therapies. With a total of 4 patents to his name, Foloppe is recognized for his innovative approaches to cancer treatment.
Latest Patents
Among his latest patents, Foloppe has developed poxviral oncolytic vectors. These inventions relate to a poxvirus that comprises a defective F4L and/or I4L gene. The compositions he has created, along with the methods and uses of such poxviruses, are aimed at therapeutic purposes, specifically for the treatment of cancer. His work in this area represents a promising advancement in cancer therapy.
Career Highlights
Johann Foloppe is currently associated with Transgene S.A., a company that focuses on developing innovative immunotherapies for cancer. His role at Transgene has allowed him to further his research and contribute to groundbreaking developments in the field of oncolytic viruses.
Collaborations
One of his notable coworkers is Philippe Erbs, with whom he collaborates on various projects within the company. Their combined expertise enhances the potential for innovative solutions in cancer treatment.
Conclusion
Johann Foloppe's work in the field of oncolytic vectors showcases his commitment to advancing cancer therapies. His patents and collaborations reflect a dedication to innovation that could significantly impact the future of medical treatments.